Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Novo Bets On ‘Chequered’ CB1r Approach In Diabetic Kidney Disease With Inversago Buy
For Up To $1.08bn
Aug 10 2023
•
By
Ayisha Sharma
Diabetes Is The Leading Cause Of Kidney Disease • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Earnings
More from Business